Derechos | Equipo Nizkor
Talks on Sputnik Light production in India close to completion, says Lavrov
The talks on the production of the Russian anti-coronavirus jab Sputnik Light in India are nearing completion, Russian Foreign Minister Sergey Lavrov told reporters following the talks with his Indian counterpart Subrahmanyam Jaishankar and the Russia-India consultations in the 2+2 format between the two countries’ defense and foreign ministers on Monday.
"The talks on Sputnik Light are nearing completion," he said when asked a respective question.
The agreement on the production of the two-component vaccine Sputnik V in the republic is also being implemented, the minister added. "Quite a large scale is expected - around hundred million doses each year," he said.
In mid-September, a committee of experts under the Drug Controller General of India (DCGI) issued a permit for intermediate tests of the third (final) stage of Sputnik Light studies in India. Once approved, Sputnik Light will be the first one-dose coronavirus vaccine to be used in India.
India currently uses three vaccines, including Covishield developed by the British-Swedish company AstraZeneca and produced by India's Serum Institute, Covaxin produced by India's Bharat Biotech, and Russia's Sputnik V. Two US vaccines, Moderna and Johnson & Johnson, have recently also been approved for emergency use in the country, though the vaccination using those jabs has not started yet in India.
[Source: Tass, New Delhi, 06Dec21]
|This document has been published on 08Dec21 by the Equipo Nizkor and Derechos Human Rights. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.|